Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
A Montana judge on Monday sided with young environmental activists who said state agencies were violating their constitutional right to a clean and healthful environment by permitting fossil fuel development without considering its effect on the climate.
Alzheimer’s mainly affects the elderly, who are eligible for Medicare, but people under 65 — even, rarely, as young as their 30s — also can get diagnosed. They are more likely to have commercial coverage.
Some doctors say the drug should be held for three weeks before sedation to accommodate the delayed emptying of the stomach, which can cause patients to inhale food and liquid into their lungs.
